Filing Details

Accession Number:
0001209191-17-038417
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-07 18:58:41
Reporting Period:
2017-06-05
Filing Date:
2017-06-07
Accepted Time:
2017-06-07 18:58:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Pharmaceuticals Inc. PCRX Pharmaceutical Preparations (2834) 510619477
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1650857 B James Jones C/O Pacira Pharmaceuticals, Inc.
5 Sylvan Way, Suite 300
Parsippany NJ 07054
Svp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-06-05 767 $43.32 9,813 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
  2. Includes 330 shares of common stock acquired under the issuer's employee stock purchase plan in June 2016.